Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06793748 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate the Safety, Tolerability, and Efficacy of PEP-TISSEEL in Subjects With Chronic Radiation Ulcer
A Phase 1 study, sponsored by Rion.
- Not yet
- Registry status
- Phase 1
- Development phase
- 184
- Enrollment target
NCT06793748: Clinical Trial Phase 1 study, sponsored by Rion.
NCT06793748 is a Phase 1 study that has not yet begun recruiting, run by Rion. The registered enrollment target is 184 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (207% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06793748, a Phase 1 study, has not yet begun recruiting, sponsored by Rion.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 184 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if drug Purified Exosome Product (PEP™) and Fibrin Sealant (TISSEEL® VH SD Kit) (PEP-TISSEEL) works to treat chronic radiation ulcer in adults and compare it with comparator TISSEEL. It will also learn about the safety of drug PEP-TISSEEL.
Interventions
- COMBINATION_PRODUCT PEP-TISSEEL
- DRUG TISSEEL Fibrin Sealant KIT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2025-06 |
| Est. Completion | 2026-02 |
| Phase | Phase 1 |
What is known before NCT06793748 opens enrollment
NCT06793748 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (207% higher).
The record links to 0 conditions, and to 2 interventions - of which PEP-TISSEEL is the first listed.
NCT06793748 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06793748 about?
NCT06793748 is a clinical study titled "Study to Evaluate the Safety, Tolerability, and Efficacy of PEP-TISSEEL in Subjects With Chronic Radiation Ulcer". The goal of this clinical trial is to learn if drug Purified Exosome Product (PEP™) and Fibrin Sealant (TISSEEL® VH SD Kit) (PEP-TISSEEL) works to treat chronic radiation ulcer in adults and compare it with comparator TISSEEL. It will also learn about the safety of drug PEP-TISSEEL.
What is the current status of trial NCT06793748?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 184 participants. The study started on 2025-06. Estimated completion is 2026-02.
What interventions are being tested in trial NCT06793748?
The interventions under investigation include: PEP-TISSEEL (COMBINATION_PRODUCT), TISSEEL Fibrin Sealant KIT (DRUG).
Who is sponsoring clinical trial NCT06793748?
This trial is sponsored by Rion, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06793748's enrollment target sits among peer trials
184 294th of 2000 higher than 1,704 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia